Table 3.

Guidelines for treatment of filarial parasite infections through preventive chemotherapy mass drug administration campaigns.

Disease	Areas not Co-endemic with Onchocerciasis	Areas Co-endemic with Onchocerciasis	Areas Co-endemic with Loiasis
Onchocer-ciasis	–	ivermectin (150–200 µg/kg)	not advised; test and not treat strategies investigated
Lymphatic filariasis	once a year DEC (6 mg/kg) and albendazole (400 mg); 2018–2019 start triple therapy in select countries	once a year ivermectin (200 µg/kg) with albendazole (400 mg)	twice a year albendazle (400 mg)
Loiasis	DEC or albendazole; treatment not always recommended due to risk of SAEs; no programs currently in place to control or eliminate loiasis

DEC, diethylcarbamazine citrate; SAEs, severe adverse events.